Compare Organon & Co. Common Stock (OGN) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Stitch Fix Inc — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while Stitch Fix Inc trades at $2.38 (market cap $326.66M). The key difference: Organon & Co. Common Stock is far larger — about 11.1× Stitch Fix Inc's market cap, and Organon & Co. Common Stock pays a 0.58% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Stitch Fix Inc for 31 Days on average.
| OGN | SFIX | |
|---|---|---|
Market Cap | $3.62B | $326.66M |
Volume | 2,892,999 | 3,004,657 |
Sector | Health | Consumer Cyclical |
52-Week High | $13.81 | $5.64 |
52-Week Low | $5.70 | $2.16 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $11.04B | $222.46M |
Dividend Yield | 0.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
Stitch Fix (SFIX) trades at $2.39, down 11.48% amid bearish technical signals and negative cash flow trends. The company shows improving fundamentals with three consecutive quarterly EPS beats and narrowing losses, though revenue remains stagnant at $1.27B. Recent news highlights fraud investigations and disappointing Q4 2026 results that missed revenue estimates, driving the stock's decline.
The outlook remains challenging with analyst consensus leaning neutral (69.7% hold) and a $3.40 price target suggesting limited upside. Key risks include ongoing legal scrutiny, weak FY27 guidance, and persistent net losses despite margin improvements. The stock's trajectory depends on reversing active client declines and achieving sustainable profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
